Pharmica Consulting has joined ProPharma Group.

Effective February 1, 2022, this site will no longer be accessible, and you will automatically be directed to our regulatory, clinical, and compliance services supporting clients throughout the full product lifecycle. Learn about our expanded services.

Inside Investigator Meetings (Part 3 – The Survey)

In previous blogs, I mentioned issues mentioned with regards to collecting feedback via surveys. However, I was able to collect a significant amount of data from attendees at various investigator meetings (21 in total, all Phase III studies). I used two different sets of standardized surveys throughout: internal (sponsor focused) and external (site focused). At the end of[…]